Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited CONSOLIDATED STATEMENT OF PROFIT AND LOSS (All amounts in Indian Rupees millions, except share data and where otherwise stated) PARTICULARS NOTE FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 INCOME Sales, gross 147,855 131,715 Less: Excise duty (829) (820) Sales, net 147,026 130,895 Service income 1,689 1,632 License fees 369 280 Other operating revenues 2.16 1,149 1,346 Revenue from operations 150,233 134,153 Other income 2.17 2,741 1,697 Total revenue 152,974 135,850 EXPENSES Cost of material consumed (including packing material consumed) 28,259 28,407 Purchase of stock-in-trade 9,420 7,398 Changes in inventories of finished goods,work-in-progress and stock-intrade 2.18 (558) (3,196) Conversion charges 1,929 2,207 Employee benefits expense 2.19 29,446 24,754 Finance costs 2.20 1,082 1,267 Depreciation and amortisation expense 2.7 7,599 6,475 Other expenses 2.21 46,801 42,075 Total expenses 123,978 109,387 Profit before exceptional and extraordinary items and tax 28,996 26,463 Exceptional items - - Profit before extraordinary items and tax 28,996 26,463 Extraordinary items - - Profit before tax 28,996 26,463 Tax expense 2.22 Current tax expense 6,242 6,568 Deferred tax expense/ (benefit) (610) 263 Profit for the year 23,364 19,632 Earnings per share 2.24 Basic - Par value ` 5/- per share 137.18 115.45 Diluted - Par value ` 5/- per share 136.59 114.90 Number of shares used in computing earnings per share Basic 170,314,506 170,044,518 Diluted 171,056,969 170,857,689 Significant accounting policies 1 The accompanying notes are an integral part of consolidated financial statements As per our report of even date attached for B S R & Co. LLP Chartered Accountants for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited Firm Registration No.: 101248W/W-100022 Supreet Sachdev Partner K Satish Reddy Chairman Membership No.: 205385 G V Prasad Co-Chairman & Chief Executive Officer Place : Hyderabad Saumen Chakraborty President & Chief Financial Officer Date : 12 May 2015 Sandeep Poddar Company Secretary 170
Consolidated Financial Statements Annual Report 2014 - 15 CONSOLIDATED CASH FLOW STATEMENT (All amounts in Indian Rupees millions, except share data and where otherwise stated) PARTICULARS FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 CASH FLOWS FROM / (USED IN) OPERATING ACTIVITIES Profit before taxation 28,996 26,463 Adjustments: Depreciation and amortisation expense 7,599 6,475 Provision for wealth tax 2 2 Profit on sale of current investments, net (729) (213) Dividend from mutual fund units (26) - Foreign exchange (gain) / loss, net 1,381 (1,107) Impairment / loss on de-recognition of intangible assets 267 86 Stock compensation expense, net 519 468 Allowance for sales returns 3,536 2,451 Interest income (1,054) (1,085) Finance costs 1,082 1,267 (Profit) / Loss on sale of fixed assets, net 144 (24) Provision for inventory obsolescence 3,635 1,941 Provision for doubtful debts, net 168 168 Provision / (reversal of provision) for doubtful advances, net 16 (2) Operating cash flows before working capital changes 45,536 36,890 Changes in operating assets and liabilities Trade receivables (10,935) (261) Inventories (5,413) (4,047) Trade payables (45) (1,019) Other assets and liabilities, net 1,556 (4,723) Cash generated from operations 30,699 26,840 Income taxes paid, net (5,464) (7,143) Net cash from operating activities 25,235 19,697 CASH FLOWS FROM / (USED IN) INVESTING ACTIVITIES Purchase of tangible and intangible assets (15,315) (10,831) Proceeds from sale of fixed assets 172 85 (Increase)/ decrease in deposit accounts (having original maturity of more than 3 months) and other bank balances 1,581 1,361 Purchase of investments (37,005) (25,091) Proceeds from sale of investments 27,386 16,594 Interest received 784 965 Cash paid for acquisition of business units, net of cash acquired (276) - Dividend received on mutual funds 26 - Acquisition of minority interest - (24) Net cash used in investing activities (22,647) (16,941) 171
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Statutory Reports • Business Resp
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Statutory Reports • Management Di
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Statutory Reports • Corporate Gov
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Statutory Reports • Additional Sh
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Statutory Reports • Board’s Rep
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Standalone Financial Statements Ann
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122: Standalone Financial Statements Ann
Page 165 and 166: Consolidated Financial Statements A
Page 171: Consolidated Financial Statements A
Page 223 and 224:
Consolidated Financial Statements A
Page 225 and 226:
Consolidated Financial Statements A
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

Create successful ePaper yourself

Delete template?

Save as template?